Enterprise Value
30.69M
Cash
215.4M
Avg Qtr Burn
-11.49M
Short % of Float
2.57%
Insider Ownership
9.47%
Institutional Own.
75.18%
Qtr Updated
09/30/23
Drug Pipeline
Powered by
Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
Drug & Indication | Stage & Event | Catalyst Date |
---|---|---|
ACU193 Details Alzheimer's disease | Phase 2 Initiation | |
ACU193 w/ ENHANZE® Details Alzheimer's disease | Phase 1 Initiation |